Please login to the form below
PureTech Health appoints chief scientific officer
Dr Joseph Bolen brings 30 years of clinical experience to the biotech
Boston, US-based PureTech Health has appointed Dr Joseph Bolen as its chief scientific officer.
Dr Bolen will be responsible for the scientific development and advancement of PureTech Health's pipeline, working with the company's scientific advisory board and R&D team.
Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.
Prior to this, Dr Bolen was chief scientific officer and global head of oncology research at Millennium, Takeda's oncology business, and has held senior R&D positions at Bristol-Myers Squibb, Hoechst Marion Roussel and Schering-Plough.
Daphne Zohar, chief executive officer of PureTech Health, said: “We are tremendously excited to bring Joe's visionary leadership and drug development expertise to PureTech.
“Joe is a seasoned industry expert who brings the ideal balance of rigor and creativity to the role of chief scientific officer, and shares our vision for identifying and nurturing innovation that can potentially redefine healthcare.”
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
